farnesene
-
Protected: Analysis: CJ to buy Metabolix’s Biopolymer Assets
.
There is no excerpt because this is a protected post.
-
Amyris, CJ CheilJedang Partnership
.
CJ CheilJedang has definitely been very busy this year in the bio-sphere. Amyris and South Korea-based CJ CheilJedang Corporation have signed a Memorandum of Understanding (MOU) to support large-scale manufacturing of Amyris’s farnesene in existing CJ facilities. The arrangement described…
-
Rivertop, Amyris expand capacities
.
These are late news but better late than never. It is refreshing to hear capacity expansion for renewable chemicals (even those that are just at pilot/demo scale) in the midst of low crude oil price environment. Montana-based Rivertop Renewables announced…
-
Amyris launches Pathways Program
.
Yes, it has been awhile since I last blogged but no apologies here as I had a good time off visiting my hometown in the Philippines the past two weeks (despite working on my newsletter while there as well). It’s…
-
Amyris achieves $1.75/liter farnesene cost
.
I am currently in Dubrovnik, Croatia, covering the ICIS Oleochemicals conference, which is about to end soon. If anybody is interested in learning more about oleochemicals and pine chemicals market, I suggest attending the incoming INFOCAST Bio-based Chemicals Summit in…
-
Amyris expands into biopharma
.
Maybe biopharma is a better bet these days than industrial renewable chemicals (especially drop-ins) with Codexis seems to be thriving on its new biopharma ground after leaving the biofuels and renewable chems market, and Amyris recently launched its”uPharm (microPharm) Discovery…
-
Turnaround for Amyris
.
Despite the current water shortage (due to drought) and electricity problems in Brazil, Amyris seems to be doing well according to the company’s third quarter earnings report. Amyris said its Brotas biorefinery plant in Brazil has been running for 3…